Unlocking the full potential of inhalation technologies and therapies

Senzer develops, manufactures and licences breakthrough respiratory products for the effective delivery of pharmaceutical cannabinoids

Breaking news

Senzer’s ISO Certification: A First for the Pharmaceutical Cannabinoid Sector

Read More

Unique respiratory cannabinoid delivery

Senzer is a pharmaceutical company which develops, manufactures and licences innovative respiratory devices for the safe and reliable delivery of pharmaceutical cannabinoids – systemic therapies that deliver acute, breakthrough and refractory treatment.

Cannabinoids have long been identified as promising treatment options for a range of conditions, including those associated with cancer treatment; however, the drawbacks of oral delivery have limited their uptake. Senzer’s breakthrough inhalation platform delivers cannabinoids with a fast onset of action and high bioavailability, providing a new safe and effective treatment option that can be easily self-administered. Our products can make a real and tangible difference to a patients quality of life by advancing the treatment options available.

At Senzer, we’re discovering new ways to make life better. From research and development through to commercialisation, we explore, innovate and modify our technologies to complement and enhance existing conventional and alternative treatments to ensure we are a leader in this field.

Recent News

Feb 20 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s ISO Certification: A First for the Pharmaceutical Cannabinoid Sector

In what is believed to be the first-ever ISO certification for the Design and Development of a medical device to deliver pharmaceutical-grade cannabinoids has been achieved by Senzer, the respiratory inhaler Company said today. Senzer said the award of ISO 13485:2016 certification, after a full evaluation of its Quality Management systems by the authorising body,...

Read More
Feb 11 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Publications

Quality World, February 2019 – Unlocking the potential of cannabinoids

Abstract: With medical cannabis receiving a high level of media interest in the past year, Senzer, a medical device and pharmaceutical company that focuses on inhaled cannabinoid therapies, tells Quality World how they are using an effective quality policy and quality management system to break new ground. In November 2018, medicinal cannabis was made available on...

Read More
Mar 19 2019
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer Scoops a Second International Design Award

Senzer has won a leading international design award for its unique respiratory inhaler, its second such prize in a month, the pharmaceutical cannabinoid company, said today. Senzer's entry - its patented Systemic inhaled Delivery Device, SiDD™ is a winner of an iF Design Award in the Medicine/Health category. The competition run by the Hannover-based iF International Forum Design...

Read More